Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
May 19, 2022 08:35 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System
May 12, 2022 08:25 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
May 05, 2022 08:20 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in...
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
May 02, 2022 08:45 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Launches Ultra-Low-Profile FlareHawk7™ Expandable Cage Implant and Innovative Instruments to Support Endoscopic, MIS Lumbar Fusion Procedures
August 17, 2021 10:42 ET
|
Accelus
PALM BEACH GARDENS, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...